<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1072">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092921</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-209</org_study_id>
    <nct_id>NCT03092921</nct_id>
  </id_info>
  <brief_title>The Evaluation of a Mask Seal for the Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
  <official_title>The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed to evaluate the performance as well as the patients overall
      acceptance of the seal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A minimum of 15 OSA participants who currently use a Full face mask will be recruited for
      the trial. Participant will be on the trial for 1 week- The participant will use the trial
      seal in-home for 1 week.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2017</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ease of use</measure>
    <time_frame>1 week in home</time_frame>
    <description>Subjective questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability</measure>
    <time_frame>1 week in home</time_frame>
    <description>Subjective questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Objective leak data</measure>
    <time_frame>1 week in home</time_frame>
    <description>Obtained from participants' device</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>F&amp;P Mask Seal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants to use trial seal in-home for 1 week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>F&amp;P Mask Seal</intervention_name>
    <description>Investigative Mask Seal to be used for OSA therapy</description>
    <arm_group_label>F&amp;P Mask Seal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (18+ years of age)

          -  Able to give consent

          -  Apnea hypopnea Index (AHI)â‰¥ 5 on diagnostic night

          -  Prescribed PAP for OSA

          -  Existing oro-nasal mask user

        Exclusion Criteria:

          -  Inability to give consent

          -  Patients who are in a coma or a decreased level of consciousness

          -  Anatomical or physiological conditions making automatic positive airway pressure
             (APAP) therapy inappropriate (e.g. unconsolidated facial structure)

          -  Commercial drivers who are investigated by New Zealand Transport Agency

          -  Current diagnosis of carbon dioxide (CO2) retention

          -  Pregnant or may think they are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Gunson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Employee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Gunson</last_name>
    <phone>+645740123</phone>
    <phone_ext>7172</phone_ext>
    <email>sarah.gunson@fphcare.co.nz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bhavi Ogra</last_name>
    <phone>+645740123</phone>
    <phone_ext>7882</phone_ext>
    <email>bhavi.ogra@fphcare.co.nz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fisher &amp; Paykel Healthcare</name>
      <address>
        <city>Auckland</city>
        <zip>2013</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Gunson, BSC, Pgdip</last_name>
      <phone>+645740123</phone>
      <phone_ext>7172</phone_ext>
      <email>sarah.gunson@fphcare.co.nz</email>
    </contact>
    <contact_backup>
      <last_name>Bhavi Ogra</last_name>
      <phone>+645740123</phone>
      <phone_ext>7882</phone_ext>
      <email>bhavi.ogra@fphcare.co.nz</email>
    </contact_backup>
    <investigator>
      <last_name>Sarah Gunson</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kayan Gonda</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 22, 2017</lastchanged_date>
  <firstreceived_date>March 22, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>For product development purposes only. Data will be deidentified.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
